Komfoderm M2 (methylprednisolone aceponate, urea) cream
22634USD

Komfoderm M2 (methylprednisolone aceponate, urea) cream

SKU:2571
To favorites
Komfoderm M2 (methylprednisolone aceponate, urea) cream glucocorticosteroid for local use + keratolytic agent, has keratolytic and moisturizing effects, helps soften the stratum corneum of the skin
Active substance:methylprednisolone aceponate, urea
Pharmacological group:Dermatology
Formulation:Cream
Expiration Date:Always fresh
In stock
$26
11
Description
Features
Reviews

Instructions for Komfoderm M2 (methylprednisolone aceponate, urea) cream

Release Form
Cream for outdoor use

Description Komfoderm M2
Cream for external use of white or almost white color, the presence of a weak specific smell is allowed.

100g
methylprednisolone acetate 0.1g
mochevina 2g
Auxiliary substances: paraffin liquid (vaseline oil) - 15 g, propylene glycol - 5 g, polysorbate 80 - 1 g, carbomer interpolymer (type A) - 1 g, tromethamol - 400 mg, methylparhydroxybenzoate - 100 mg, water purified - up to 100 g.

10 g - aluminium tubes (1) - cardboard packs.
30 g - aluminium tubes (1) - cardboard packs.

ATC codes Komfoderm M2
D07XC Corticosteroids are highly active in combination with other drugs

Clinical-pharmacological groups / Group affiliation
Preparation with anti-inflammatory and moisturizing effect for external use

Active substance Komfoderm M2

  • methylprednisolone acetat
  • mochevina

Pharmaco-therapeutic group Komfoderm M2

Glucocorticosteroid for local use

Storage Conditions
The drug should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.

Best before date
The shelf life is two years. Do not apply after expiry date.

Pharmacological effect Komfoderm M2

Comfoderm® M2 is a combination drug, the effect of which is caused by its constituent components.

Methylprednisolone acetate is a non-halogenated synthetic steroid. When applied externally, methylprednisolone aceponate suppresses inflammatory and allergic skin reactions, as well as those associated with enhanced proliferation, resulting in a reduction of objective symptoms of inflammation (erythema, edema, urination) and subjective sensations (itching, irritation, pain, etc.).

Testimony Komfoderm M2

  • Inflammatory skin diseases sensitive to therapy with topical GCS and accompanied by keratinization disorder:
  • atopic dermatitis, neurodermatitis;
  • true eczema;
  • microbial eczema;
  • simple contact dermatitis;
  • allergic (contact) dermatitis;
  • dyhydrotic eczema.

Method of use, course and dosage Komfoderm M2

The preparation is used externally.
The preparation is applied once a day with a thin layer on the affected areas of the skin.
As a rule, the duration of continuous daily treatment with Comfoderm® M2 should not exceed 12 weeks. In the treatment of patients with facial skin lesions, the treatment should not exceed 5 days.

  • Nosology Komfoderm M2 (ICD codes)
  • L20.8
  • Other atopic dermatitis (neurodermatitis, eczema)
  • L23
  • Allergic contact dermatitis
  • L24
  • Simple Irritable [irritant] Contact Dermatitis
  • L28.0
  • Simple chronic lychee (limited neurodermatitis)
  • L30.0
  • Monetoid eczema
  • L30.1
  • Dyhydrosis [Pompholics]
  • L30.3
  • Infectious dermatitis (infectious eczema)
Features
Active substance
Pharmacological group
Formulation
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating